Substantial Disparities Seen in Cancer Cases, Deaths Among Men
Cancer deaths projected to almost double by 2050, with more than twofold increase for older men and low-, medium HDI countries
Cannabis-Related Disorder Linked to Risk for Head and Neck Cancer
Risk increased for any head and neck cancer, especially oral, oropharyngeal, and laryngeal cancer
Gene Expression Signature Predicts Immune-Related Adverse Events in Melanoma Patients
Gene expression signature predicts irAEs in melanoma patients treated with ipilimumab/nivolumab
Rheumatoid Arthritis Tied to Higher Risk for Lung Cancer
Rheumatoid arthritis-interstitial lung disease shows particularly high risk
FDA Approves Voranigo for Grade 2 Astrocytoma or Oligodendroglioma
This is the first FDA-approved systemic therapy for patients with a susceptible IDH1 or IDH2 mutation
Racial Differences Identified in Frequency of Biopsy for Psoriasis
Skin biopsies, indicating diagnostic uncertainty, performed most frequently for Black patients
Blood Test Results Can Enhance Assessment of Cancer Risk
Blood test results enhance assessment of risk for patients presenting with nonspecific abdominal symptoms
CDC Presents Provisional Mortality Data for 2023 in the United States
Number of deaths from COVID-19 was 68.9 percent lower than in 2022
Complex Interaction Seen Between Social Determinants of Health, Mortality
A scoring system can help identify individuals at high risk for mortality based on their combination of social determinants of health
